Shek Kevin, Alcock Susan, Ghrooda Esseddeeg, Trivedi Anurag, McEachern James, Kaderali Zul, Shankar Jai
Radiology, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada.
Radiology, University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada.
J Neurointerv Surg. 2022 May;14(5). doi: 10.1136/neurintsurg-2021-017502. Epub 2021 May 25.
The effectiveness and safety of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVO) in the anterior intracranial circulation for patients with acute ischemic stroke (AIS) has yet to be definitively established. We compared outcomes in patients undergoing EVT for large vessel occlusion (LVO) versus those with MeVO.
This retrospective cohort study, using an intention to treat design, compared the 90-day modified Rankin Scale (mRS) score between 43 patients with MeVO and 199 with LVO in the anterior intracranial circulation. Secondary outcome measures included vessel recanalization using the Thrombolysis in Cerebral Infarction (TICI) score, procedural complications, post-EVT intracranial hemorrhage (ICH), and infarct size.
The rate of good functional outcome (90-day mRS 0-2) was higher in patients with LVO than in those with MeVO (32.9% vs 27%), but this was not statistically significant (p=0.19). The rate of EVT procedural complications was also not significantly different between the groups (p=0.10), nor was the rate of ICH (p=0.30). There was also no significant difference in TICI scores between groups (p=0.12). Infarct size was larger in the LVO group (p<0.01). Multivariate analysis showed older age, not receiving recombinant tissue plasminogen activator (r-tPA), and larger infarct size were independent predictors of poor functional outcome at 90 days.
The 90-day mRS and rate of periprocedural complications were not significantly different between patients treated for LVO and those treated for MeVO with EVT. Older age, not receiving r-tPA, and larger infarct size were independent predictors of poor outcome at 90 days.
急性缺血性卒中(AIS)患者颅内前循环中血管内血栓切除术(EVT)治疗中型血管闭塞(MeVO)的有效性和安全性尚未明确确立。我们比较了接受EVT治疗的大血管闭塞(LVO)患者与MeVO患者的结局。
本回顾性队列研究采用意向性治疗设计,比较了43例MeVO患者和199例颅内前循环LVO患者的90天改良Rankin量表(mRS)评分。次要结局指标包括使用脑梗死溶栓(TICI)评分评估的血管再通情况、手术并发症、EVT术后颅内出血(ICH)和梗死灶大小。
LVO患者的良好功能结局(90天mRS 0-2)发生率高于MeVO患者(32.9%对27%),但差异无统计学意义(p=0.19)。两组间EVT手术并发症发生率也无显著差异(p=0.10),ICH发生率亦如此(p=0.30)。两组间TICI评分也无显著差异(p=0.12)。LVO组的梗死灶更大(p<0.01)。多因素分析显示,年龄较大、未接受重组组织型纤溶酶原激活剂(r-tPA)治疗以及梗死灶较大是90天时功能结局不良的独立预测因素。
接受EVT治疗的LVO患者和MeVO患者的90天mRS及围手术期并发症发生率无显著差异。年龄较大、未接受r-tPA治疗以及梗死灶较大是90天时结局不良的独立预测因素。